GUILD Maui 2026 (Videos + PDFs)
Comprehensive Gastroenterology, IBD, Hepatology & Advanced GI Clinical Updates
The GUILD Maui 2026 Conference is a premier four-day continuing medical education (CME) program dedicated to delivering cutting-edge updates in gastroenterology, inflammatory bowel disease (IBD), hepatology, and advanced digestive health care. Hosted in Maui, Hawaii, this internationally recognized meeting brings together leading experts in gastroenterology to provide evidence-based education, practical clinical guidance, and multidisciplinary perspectives on the most important developments in digestive diseases. The 2026 conference featured a hybrid format with both in-person and virtual participation and attracted hundreds of healthcare professionals from around the world.
The curriculum emphasizes real-world clinical management, emerging therapies, guideline updates, challenging case discussions, and the integration of innovative technologies such as artificial intelligence in gastroenterology. Through expert-led lectures, case reviews, panel discussions, and specialty bootcamp sessions, participants gain practical knowledge that can be immediately applied in clinical practice.
Course Features
• Comprehensive Video Conference Recordings
• Downloadable PDF Presentations
• Four-Day CME Educational Program
• Internationally Recognized GI Faculty
• Inflammatory Bowel Disease (IBD) Updates
• Hepatology & Liver Disease Reviews
• General Gastroenterology Sessions
• Artificial Intelligence in GI Medicine
• Case-Based Learning & Panel Discussions
• Practical Clinical Management Strategies
Target Audience
This course is ideal for:
• Gastroenterologists
• GI Nurse Practitioners
• Physician Assistants
• Hepatologists
• Internal Medicine Physicians
• Advanced Practice Providers (APPs)
• Gastroenterology Fellows
• Digestive Disease Specialists
• Academic Clinicians
• Healthcare Professionals Involved in GI Care
It is particularly valuable for clinicians seeking:
• Gastroenterology CME
• IBD Education
• Hepatology Updates
• Colon Cancer Screening Updates
• Eosinophilic Esophagitis Education
• Crohn’s Disease Management
• Ulcerative Colitis Treatment Strategies
• Advanced Digestive Disease Training
Program Overview
The GUILD Conference has become one of the most respected educational meetings in clinical gastroenterology by combining world-class faculty with practical, patient-centered education. The 2026 meeting focused on major advances in inflammatory bowel disease, liver disease, colorectal cancer prevention, eosinophilic gastrointestinal disorders, gut-brain interactions, and emerging technologies that are transforming digestive healthcare.
Participants receive comprehensive reviews of the latest clinical evidence, therapeutic innovations, and guideline updates while learning directly from internationally recognized experts in gastroenterology and hepatology. The conference also includes dedicated educational opportunities for nurse practitioners, physician assistants, and GI fellows.
Learning Objectives
Upon completion of this activity, participants will be able to:
• Apply current evidence-based management strategies for inflammatory bowel disease
• Integrate new therapies into the treatment of Crohn’s disease and ulcerative colitis
• Evaluate advances in hepatology and chronic liver disease management
• Implement updated colorectal cancer screening recommendations
• Recognize and manage eosinophilic esophagitis and other esophageal disorders
• Interpret emerging data regarding artificial intelligence in gastroenterology
• Utilize multidisciplinary approaches for complex GI disorders
• Improve patient outcomes through evidence-based clinical decision making
• Incorporate new diagnostic and therapeutic technologies into practice
• Apply expert recommendations to challenging clinical cases
Core Topics Covered
Inflammatory Bowel Disease (IBD)
• Crohn’s Disease
• Ulcerative Colitis
• Perianal Crohn’s Disease
• Postoperative Crohn’s Disease
• Alternative Therapies in IBD
• Pregnancy & IBD
Hepatology & Liver Disease
• Hepatitis B
• Cirrhosis Assessment
• Non-Invasive Liver Testing
• Primary Biliary Cholangitis
• MASLD & Metabolic Liver Disease
• Complex Liver Cases
General Gastroenterology
• Colon Cancer Screening
• Irritable Bowel Syndrome
• Gut-Brain Axis Disorders
• Autoimmune Pancreatitis
• Alpha-Gal Syndrome
• Complex GI Case Discussions
Esophageal Disorders
• Eosinophilic Esophagitis (EoE)
• GERD Management
• EoE Case Reviews
• Esophageal Disease Updates
Artificial Intelligence & Innovation
• Artificial Intelligence in Gastroenterology
• Computer-Aided Detection
• Emerging Diagnostic Technologies
• Future Trends in GI Practice
Multidisciplinary Care
• Dermatologic Manifestations of GI Disease
• Rheumatology & GI Disorders
• Integrated Patient Management
• Specialty Collaboration
Educational Features
✔ Expert Gastroenterology Faculty
✔ Comprehensive IBD & Hepatology Coverage
✔ Practical Case-Based Learning
✔ Evidence-Based Clinical Updates
✔ Multidisciplinary Approach to Digestive Diseases
✔ GI Fellow & APP Education Opportunities
✔ Artificial Intelligence in GI Practice
✔ Immediate Clinical Relevance
Why This Course Stands Out
✔ Premier Gastroenterology CME Conference
✔ Extensive IBD & Liver Disease Education
✔ World-Class Faculty
✔ Practical Clinical Focus
✔ Strong Integration of Emerging Technologies
✔ Dedicated Training for APPs and Fellows
✔ Comprehensive Coverage of Modern GI Practice
✔ Hybrid Learning Format
Clinical & Educational Value
The GUILD Maui 2026 Conference provides an advanced and highly practical review of contemporary gastroenterology, hepatology, and digestive disease management. By integrating updates in inflammatory bowel disease, liver disorders, colorectal cancer screening, eosinophilic esophagitis, gut-brain disorders, and artificial intelligence applications, the conference equips clinicians with the knowledge needed to provide state-of-the-art patient care. The combination of expert faculty, case-based education, and multidisciplinary perspectives makes this program an outstanding resource for gastroenterologists, advanced practice providers, and digestive disease specialists.
Course Objectives
At the end of this course, participants should be able to:
1. Describe the latest treatment options for ulcerative colitis and apply them in practice
2. Describe the latest treatment options for Crohn’s
disease and apply them in practice
3. Discuss the management of microscopic, checkpoint and c. dificile colitis
4. Understand new therapies for cholestatic liver diseases
5. List pharmacological therapies for irritable bowel syndrome
6. Recognize rheumatologic and dermatologic complications of IBD
7. Understand the appropriate use of small molecule therapies in IBD
8. Describe the latest treatment options for MASLD
9. Manage drug induced liver disease
10. Manage hepatitis B
11. Describe the role of the gastroenterologist in managing colon cancer screening and
surveillance
12. Apply new AI tools in practice
13. Understand evaluation of the patient with eosinophilic esophagitis
14. Understand the evidence-based detection and management of dysplasia in
IBD








